WST

West Pharmaceutical Services
D

WST

Arincen83/100B

West Pharmaceutical Services free cash flow 1989–2026

West Pharmaceutical Services's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 150.40M USD, up 12.3% on the same quarter a year before. West Pharmaceutical Services's free cash flow over the last twelve months was 453.40M USD, up 19.6% on the twelve months before. In fiscal year 2025 it was 468.90M USD, up 69.6% on the year before.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

Free cash flow

Free cash flow · +19.2% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 2026453.40M+19.60%13.35%654.50M-201.10M6.31
FY202531 Dec 2025468.90M+69.65%15.26%754.80M-285.90M6.45
FY202431 Dec 2024276.40M-33.32%9.56%653.40M-377.00M3.75
FY202331 Dec 2023414.50M-5.67%14.05%776.50M-362.00M5.50
FY202231 Dec 2022439.40M+32.91%15.23%724.00M-284.60M5.80
FY202131 Dec 2021330.60M+10.90%11.68%584.00M-253.40M4.33
FY202031 Dec 2020298.10M+23.80%13.89%472.50M-174.40M3.93
FY201931 Dec 2019240.80M+30.94%13.06%367.20M-126.40M3.19
FY201831 Dec 2018183.90M+38.79%10.70%288.60M-104.70M2.44
FY201731 Dec 2017132.50M+169.31%8.28%263.30M-130.80M1.75
FY201631 Dec 201649.20M-39.11%3.26%219.40M-170.20M0.66
FY201531 Dec 201580.80M+14.12%5.78%212.40M-131.60M1.09
FY201431 Dec 201470.80M+9.43%4.98%182.90M-112.10M0.97
FY201331 Dec 201364.70M+16.79%4.73%220.50M-155.80M0.91
FY201231 Dec 201255.40M+63.42%4.37%187.40M-132.00M0.77
FY201131 Dec 201133.90M-47.44%2.84%130.70M-96.80M0.46
FY201031 Dec 201064.50M+115.72%5.84%138.30M-73.80M0.88
FY200931 Dec 200929.90M—2.83%137.70M-107.80M0.41
FY200831 Dec 2008-4.10M—-0.39%135.00M-139.10M-0.06
FY200731 Dec 2007-200.00K-100.37%-0.02%129.20M-129.40M-0.00
FY200631 Dec 200653.50M+69.84%5.86%143.80M-90.30M0.80
FY200531 Dec 200531.50M+173.91%4.50%85.60M-54.10M0.48
FY200431 Dec 200411.50M+36.90%2.12%68.90M-57.40M0.19
FY200331 Dec 20038.40M-48.15%1.71%69.20M-60.80M0.14
FY200231 Dec 200216.20M—3.86%53.90M-37.70M0.28
FY200131 Dec 2001-11.40M—-2.87%32.70M-44.10M-0.20
FY200031 Dec 2000-8.70M-245.00%-2.02%48.60M-57.30M-0.15
FY199931 Dec 19996.00M—1.28%69.40M-63.40M0.10
FY199831 Dec 1998-5.70M-117.12%-1.27%71.00M-76.70M-0.09
FY199731 Dec 199733.30M+5.05%7.36%67.70M-34.40M0.50
FY199631 Dec 199631.70M+114.19%6.91%63.40M-31.70M0.48
FY199531 Dec 199514.80M-34.80%3.58%46.10M-31.30M0.22
FY199431 Dec 199422.70M+354.00%6.22%49.80M-27.10M0.35
FY199331 Dec 19935.00M-56.90%1.43%38.50M-33.50M0.08
FY199231 Dec 199211.60M-38.62%3.43%34.00M-22.40M0.18
FY199131 Dec 199118.90M+575.00%5.73%44.40M-25.50M0.31
FY199031 Dec 19902.80M-67.44%0.87%36.00M-33.20M0.04
FY198931 Dec 19898.60M—2.79%42.90M-34.30M0.13

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about West Pharmaceutical Services's free cash flow

Source: Financial Modeling Prep